Related Experiment Video
Updated: Aug 7, 2026
07:05
A Protocol for the Administration of Real-Time fMRI Neurofeedback Training
Published on: August 24, 2017
Pharmacy practice in the United States Air Force
American Journal of Hospital Pharmacy
|April 1, 1987
Summary
The United States Air Force Medical Service provides comprehensive pharmaceutical services across 121 facilities, emphasizing ambulatory care and utilizing the TRIPHARM system. Future efforts focus on training and technology to enhance these essential military health services.
Area of Science:
- Health Services Research
- Military Pharmacy Practice
Background:
- The United States Air Force (USAF) Medical Service operates 121 medical treatment facilities (MTFs) globally.
- Its mission includes providing medical support for combat forces and healthcare for military personnel and their families.
Purpose of the Study:
- To describe the current status of pharmaceutical services within the USAF Medical Service.
- To outline the operational framework and future directions for military pharmacy.
Main Methods:
- Review of governing regulations including federal law, professional standards, Department of Defense directives, and Air Force regulations.
- Description of service delivery models, emphasizing ambulatory and clinical pharmacy.
- Identification of technological support systems like TRIPHARM.
Main Results:
- Pharmaceutical services are regulated and standardized across USAF MTFs.
- Emphasis is placed on ambulatory care, with clinical services integrated into many facilities.
- The TRIPHARM computer system supports pharmaceutical operations.
Conclusions:
- The USAF Medical Service is committed to maintaining contemporary pharmaceutical services.
- Future enhancements will involve graduate-level training for pharmacists, adoption of new technologies, and improved information exchange between MTFs.
Related Concept Videos
01:17Healthcare Agencies II
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources, and lay...
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources, and lay...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...